ROLE OF DOPAMINE D-1 AND D-2 RECEPTORS IN THE REGULATION OF NEUROTENSIN SYSTEMS OF THE NEOSTRIATUM AND THE NUCLEUS ACCUMBENS

被引:58
作者
MERCHANT, KM [1 ]
GIBB, JW [1 ]
HANSON, GR [1 ]
机构
[1] UNIV UTAH,DEPT PHARMACOL & TOXICOL,113 SKAGGS HALL,SALT LAKE CITY,UT 84112
关键词
D O I
10.1016/0014-2999(89)90098-8
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:409 / 412
页数:4
相关论文
共 10 条
[1]   EFFECTS OF ACUTE AND LONG-TERM TREATMENT WITH NEUROLEPTICS ON REGIONAL TELENCEPHALIC NEUROTENSIN LEVELS IN THE MALE-RAT [J].
FREY, P ;
FUXE, K ;
ENEROTH, P ;
AGNATI, LF .
NEUROCHEMISTRY INTERNATIONAL, 1986, 8 (03) :429-434
[2]  
GOVONI S, 1980, J PHARMACOL EXP THER, V215, P413
[3]  
LETTER AA, 1987, J PHARMACOL EXP THER, V241, P443
[4]   CHARACTERIZATION OF DOPAMINERGIC INFLUENCE ON STRIATAL-NIGRAL NEUROTENSIN SYSTEMS [J].
LETTER, AA ;
MATSUDA, LA ;
MERCHANT, KM ;
GIBB, JW ;
HANSON, GR .
BRAIN RESEARCH, 1987, 422 (01) :200-203
[5]   CHANGES IN THE LIMBIC NEUROTENSIN SYSTEMS INDUCED BY DOPAMINERGIC DRUGS [J].
MERCHANT, KM ;
LETTER, AA ;
GIBB, JW ;
HANSON, GR .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 153 (01) :1-9
[6]   THE INTERACTION OF NEUROTENSIN WITH DOPAMINERGIC PATHWAYS IN THE CENTRAL-NERVOUS-SYSTEM - BASIC NEUROBIOLOGY AND IMPLICATIONS FOR THE PATHOGENESIS AND TREATMENT OF SCHIZOPHRENIA [J].
NEMEROFF, CB .
PSYCHONEUROENDOCRINOLOGY, 1986, 11 (01) :15-37
[7]   INTERACTIONS BETWEEN NEUROTENSIN AND DOPAMINE IN THE BRAIN - AN OVERVIEW [J].
QUIRION, R .
PEPTIDES, 1983, 4 (05) :609-615
[9]   OPPOSITE RESPONSES IN THE STRIATO-NIGRAL SUBSTANCE-P SYSTEM TO D1-RECEPTOR AND D2-RECEPTOR ACTIVATION [J].
SONSALLA, PK ;
GIBB, JW ;
HANSON, GR .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1984, 105 (1-2) :185-187
[10]   EFFECT OF DOPAMINE RECEPTOR AGONISTS AND ANTAGONISTS ON RELEASE OF DOPAMINE IN RABBIT CAUDATE-NUCLEUS INVITRO [J].
STARKE, K ;
REIMANN, W ;
ZUMSTEIN, A ;
HERTTING, G .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1978, 305 (01) :27-36